Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and …

BH Segal, R Herbrecht, DA Stevens… - Clinical infectious …, 2008 - academic.oup.com
Invasive fungal diseases (IFDs) have become major causes of morbidity and mortality
among highly immunocompromised patients. Authoritative consensus criteria to diagnose …
被引用次数：491 相关文章
[PDF] unil.ch

[PDF][PDF] Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research …

BH Segal, R Herbrecht, DA Stevens… - Clinical Infectious …, 2008 - serval.unil.ch
Invasive fungal diseases (IFDs) have become major causes of morbidity and mortality
among highly immunocompromised patients. Authoritative consensus criteria to diagnose …

Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and …

BH Segal, R Herbrecht, DA Stevens… - CLINICAL INFECTIOUS …, 2008 - air.unimi.it
Invasive fungal diseases (IFDs) have become major causes of morbidity and mortality
among highly immunocompromised patients. Authoritative consensus criteria to diagnose …
[HTML] nih.gov

[HTML][HTML] Defining Responses to Therapy and Study Outcomes in Clinical Trials of Invasive Fungal Diseases: Mycoses Study Group and European Organization for …

BH Segal, R Herbrecht, DA Stevens… - … diseases: an official …, 2008 - ncbi.nlm.nih.gov
Invasive fungal diseases (IFDs) have become major causes of morbidity and mortality
among highly immunocompromised patients. Authoritative consensus criteria to diagnose …

[引用][C] Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research …

BH Segal, R Herbrecht, DA Stevens… - 2008 - repository.ubn.ru.nl
Invasive fungal diseases (IFDs) have become major causes of morbidity and mortality
among highly immunocompromised patients. Authoritative consensus criteria to diagnose …

Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and …

BH Segal, R Herbrecht, DA Stevens… - 2008 - cabidigitallibrary.org
Invasive fungal diseases (IFDs) have become major causes of morbidity and mortality
among highly immunocompromised patients. Authoritative consensus criteria to diagnose …

Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and …

BH Segal, R Herbrecht, DA Stevens… - Clinical Infectious …, 2008 - pure.johnshopkins.edu
Invasive fungal diseases (IFDs) have become major causes of morbidity and mortality
among highly immunocompromised patients. Authoritative consensus criteria to diagnose …

Defining Responses to Therapy and Study Outcomes in Clinical Trials of Invasive Fungal Diseases: Mycoses Study Group and European Organization for Research …

BH Segal, R Herbrecht, DA Stevens… - Clinical Infectious …, 2008 - search.ebscohost.com
Invasive fungal diseases (IFDs) have become major causes of morbidity and mortality
among highly immunocompromised patients. Authoritative consensus criteria to diagnose …

Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and …

BH Segal, R Herbrecht, DA Stevens… - … Diseases: an Official …, 2008 - europepmc.org
Invasive fungal diseases (IFDs) have become major causes of morbidity and mortality
among highly immunocompromised patients. Authoritative consensus criteria to diagnose …

Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and …

BH Segal, R Herbrecht, DA Stevens… - Clinical Infectious …, 2008 - scholars.uthscsa.edu
Invasive fungal diseases (IFDs) have become major causes of morbidity and mortality
among highly immunocompromised patients. Authoritative consensus criteria to diagnose …